A growing body of research indicates that popular weight-loss drugs, such as Ozempic and Wegovy, may have additional benefits. These medications might help treat or even prevent certain types of cancer. This is an unexpected advantage linked with GLP-1s, a class of drugs now used by one-in-eight adults in the United States.
William Brangham reports on this new finding as part of his coverage for PBS News. Brangham is known for his work as an award-winning correspondent, producer, and substitute anchor for PBS News Hour. He also hosts the show Horizons from PBS.
Lawsuit Filed Over Preeclampsia Death in Texas Amid Abortion Ban Controversy 
Illinois American Water Faces Opposition Over Proposed Rate Increase 
Porsha Williams Opens Up About Emergency Surgery and Health Challenges 
Discussing Weight-Loss Medication with Children: A Parent’s Approach 
Conjoined Twins Separated in Complex Surgery 
Genetic Mutation Linked to Elevated Lung Cancer Risk